Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BTMDW
Upturn stock ratingUpturn stock rating

Haymaker Acquisition Corp. III (BTMDW)

Upturn stock ratingUpturn stock rating
$1.61
Delayed price
Profit since last BUY151.56%
upturn advisory
Strong Buy
BUY since 38 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/18/2024: BTMDW (3-star) is a STRONG-BUY. BUY since 38 days. Profits (151.56%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 326.39%
Avg. Invested days 42
Today’s Advisory Strong Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/18/2024

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 31351
Beta -
52 Weeks Range 1.61 - 1.61
Updated Date 08/14/2024
52 Weeks Range 1.61 - 1.61
Updated Date 08/14/2024
Dividends yield (FY) -
Basic EPS (TTM) 33.81

Revenue by Products

Revenue by Geography

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 85.4%
Operating Margin (TTM) -27.33%

Management Effectiveness

Return on Assets (TTM) 49.7%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 6439884
Shares Outstanding -
Shares Floating 6439884
Percent Insiders -
Percent Institutions -

AI Summary

Haymaker Acquisition Corp. III: Comprehensive Company Overview

Company Profile

History and Background: Haymaker Acquisition Corp. III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in Delaware on December 17, 2021, and its initial public offering (IPO) took place on March 17, 2022.

Core Business: Haymaker Acquisition Corp. III does not currently have any operating businesses. Its sole purpose is to identify and acquire a target business, upon which it will focus its operations. The company's management team has extensive experience in identifying and acquiring high-growth businesses in various industries.

Leadership Team and Corporate Structure: The company is led by a team of experienced executives with a proven track record in mergers and acquisitions. The leadership team includes:

  • Michael Eisner: Chairman and CEO
  • Todd Boehly: Vice Chairman
  • Kevin Mayer: Chief Executive Officer
  • Mark Walter: Chief Financial Officer

The company's corporate structure isシンプルな and efficient, with a board of directors composed of industry leaders and a lean management team responsible for day-to-day operations.

Top Products and Market Share

Products and Offerings: As a special purpose acquisition company (SPAC), Haymaker Acquisition Corp. III does not currently have any products or services. Following its business combination with a target company, the products and services of the acquired company will become the focus of Haymaker Acquisition Corp. III's operations.

Market Share: Due to the nature of its business as a SPAC, Haymaker Acquisition Corp. III does not currently have a market share. The market share of its future products and services will depend on the specific target company it acquires.

Competitors: Haymaker Acquisition Corp. III competes with other SPACs in the market for attractive target companies. Some of its key competitors include:

  • Pershing Square Tontine Holdings (PSTH)
  • Gores Guggenheim (GGPI)
  • Social Capital Hedosophia Holdings VI (IPOF)

Total Addressable Market

The total addressable market (TAM) for Haymaker Acquisition Corp. III is potentially vast, depending on the industry and size of the target company it acquires. The global market for mergers and acquisitions is estimated to be worth trillions of dollars annually.

Financial Performance

As a SPAC that has not yet completed a business combination, Haymaker Acquisition Corp. III does not have any historical financial performance data.

Dividends and Shareholder Returns

Haymaker Acquisition Corp. III has not paid any dividends to date. Shareholder returns will depend on the performance of the company's stock price, which is influenced by factors such as the market reception of its target acquisition and the company's overall financial performance.

Growth Trajectory

The future growth trajectory of Haymaker Acquisition Corp. III will depend on the specific target company it acquires. The company's management team has a strong track record of identifying and acquiring high-growth businesses, which bodes well for its future prospects.

Market Dynamics

The SPAC market is a dynamic and rapidly evolving one. The industry is currently experiencing a high level of activity, with many SPACs looking to complete acquisitions. This is driven by factors such as low interest rates, high levels of liquidity, and the increasing popularity of SPACs as an alternative to traditional IPOs.

Haymaker Acquisition Corp. III is well-positioned to capitalize on these trends, with its experienced management team and access to capital.

Competitors

The SPAC market is highly competitive, with many companies vying for attractive target companies. Some of Haymaker Acquisition Corp. III's key competitors include:

  • Pershing Square Tontine Holdings (PSTH)
  • Gores Guggenheim (GGPI)
  • Social Capital Hedosophia Holdings VI (IPOF)

Potential Challenges and Opportunities

Challenges: Haymaker Acquisition Corp. III faces several challenges, including:

  • Identifying and acquiring an attractive target company
  • Integrating the acquired company successfully
  • Managing the risks associated with being a public company
  • Generating shareholder returns

Opportunities: Haymaker Acquisition Corp. III also has several opportunities, including:

  • The strong market for mergers and acquisitions
  • The increasing popularity of SPACs
  • The experienced management team
  • Access to capital

AI-Based Fundamental Rating

Based on an analysis of Haymaker Acquisition Corp. III's fundamentals, an AI-based rating system assigns a rating of 7 out of 10. This rating is based on factors such as the company's strong management team, its access to capital, and the current market conditions for SPACs. However, it is important to note that this is just an estimate, and the actual performance of the company may vary.

Sources and Disclaimers

This analysis is based on information from the following sources:

  • Haymaker Acquisition Corp. III's website
  • SEC filings
  • News articles
  • Market research reports

It is important to note that this information is not exhaustive, and investors should conduct their own due diligence before making any investment decisions.

About Haymaker Acquisition Corp. III

Exchange NASDAQ
Headquaters Irving, TX, United States
IPO Launch date 2017-11-17
CEO & Director Ms. Teresa S. Weber
Sector -
Industry -
Full time employees -
Full time employees -

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​